Reckitt, GSK balance risk-reward in high-stakes Pfizer fight

LONDON (Reuters) – The leaders of GlaxoSmithKline and Reckitt Benckiser — two of Britain’s best-known but underperforming companies — are in a high-stakes battle for a dose of Advil to ease their pain.

Source: Reuters

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>